1μg (R: reducing condition, N: non-reducing condition).
MSLN Fc Chimera Protein, Cynomolgus
MSLN Fc Chimera Protein, Cynomolgus
Price:
Regular price
$296 USD
Regular price
Sale price
$296 USD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Species | Cynomolgus |
| Synonyms | CAK1; Mesothelin; MPF; MPFSMRP; SMR |
| Accession | A0A2K5TW94(UniParc.UPI000C7396BF) |
| Amino Acid Sequence | Asp296-Gly580, with C-terminal Fc |
| Expression System | HEK293 |
| Molecular Weight | 68-80kDa (Reducing) |
| Purity | >95% by SDS-PAGE & SEC-HPLC |
| Endotoxin | <0.1EU/μg |
| Conjugation | Unconjugated |
| Tag | Human Fc Tag |
| Physical Appearance | Lyophilized Powder |
| Storage Buffer | PBS, PH7.4, 5% trehalose，5% mannitol |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
| Reference | Chang K. et al. (1996) Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. PNAS. 93(1): 136-140. |
Background
Mesothelin (MSLN) is also known as CAK1 antigen, Pre-pro-megakaryocyte potentiating factor, which belongs to the mesothelin family. Mesothelin/MSLN can be proteolytically cleaved into the following two chains by a furin-like convertase: Megakaryocyte-potentiating factor (MPF) and the cleaved form of mesothelin. Both MPF and the cleaved form of mesothelin are N-glycosylated. Mesothelin/MSLN can interacts with MUC16. The membrane-anchored form of MSLN may play a role in cellular adhesion. MPF potentiates megakaryocyte colony formation in vitro. Mesothelin (MSLN) is a lineage restricted cell surface protein expressed in about 30% of human cancers and high MSLN expression is associated with poor survival in several different cancers. The restricted expression of MSLN in normal tissue and its frequent expression in cancers make MSLN an excellent target for antibody-based therapies.
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of MSLN Fc Chimera Protein, Cynomolgus is more than 95% determined by SEC-HPLC.
ELISA
Immobilized MSLN Fc Chimera Protein, Cynomolgus (Cat. No. UA011043) at 2.0μg/mL (100μL/well) can bind Biotinylated Anti-Human MSLN Monoclonal Antibody (Amatuximab) with EC50 of 4.66-7.64 ng/ mL.
